AtaiBeckley Inc (ATAI) Stock Price, Quote, News & History

ATAINASDAQ
$4.13
-0.20-4.50%
Last update: Apr 29, 12:09 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-102.68M
Investing Cash Flow (TTM)
-109.13M
Financing Cash Flow (TTM)
269.48M
Free Cash Flow (TTM)
-113.54M
Capital Expenditure (TTM)
-10.87M
Net Change in Cash (TTM)
57.68M

Analyst Trends and Forecast

1
Dec 25
1
Jan
4
Mar
2
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.33B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
239.88
PB Ratio (TTM)
7.16
Earnings Yield % (TTM)
-67.21%
Earnings Yield % (FWD)
-8.78%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.60

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-
Total Cash
$85.30M
Debt to Equity
0.01
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
-

Key Statistics

Open
$4.31
Close
-
Volume / Avg.
1.22M / 5.65M
Day Range
$4.13 - $4.35
52 Wk Range
1.29 - 6.75
Market Cap
$1.52B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
8.43%
Days to Cover
8.82

About

Sector
Health Care
Industry
Pharmaceuticals
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebuf...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy AtaiBeckley (ATAI) stock?

A

You can purchase shares of AtaiBeckley (NASDAQ:ATAI) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for AtaiBeckley (ATAI) stock?

A

AtaiBeckley has a consensus price target of $14.27.

Q

What is the current price for AtaiBeckley (ATAI)?

A

The stock price for AtaiBeckley (NASDAQ: ATAI) is $4.135 last updated April 29, 2026 at 12:09 PM EDT.

Q

Does AtaiBeckley (ATAI) pay a dividend?

A

There are no upcoming dividends for AtaiBeckley.

Q

When is AtaiBeckley (NASDAQ:ATAI) reporting earnings?

A

AtaiBeckley does not have any upcoming earnings scheduled.

Q

Is AtaiBeckley (ATAI) going to split?

A

There is no upcoming split for AtaiBeckley.

Q

What sector and industry does AtaiBeckley (ATAI) operate in?

A

AtaiBeckley is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.